How early-life infections and HIV exposure shape heart and metabolic health in South African children

Early life determinants of cardiometabolic health from birth to adolescence amongst HIV-exposed and unexposed South African children

NIH-funded research Hartford Hospital · NIH-11394076

Tracking how early infections and HIV exposure affect metabolism and early heart health in South African children from birth through early adolescence.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHartford Hospital NIH-funded
Lab location1 site (Hartford, United States)
Project IDNIH-11394076 on NIH RePORTER

What this research studies

If your child is part of this work, researchers follow children born to mothers with and without HIV in South Africa, taking blood samples from birth through early adolescence to measure 250 metabolites and markers of inflammation. They compare children who were exposed to HIV but did not acquire it (HEU) with children who were not exposed (HU) to see how early infections change metabolic profiles over time. The team links those molecular changes to early signs of heart and metabolic problems to identify pathways that raise risk. The project uses the existing Drakenstein Child Health Study samples and health records to map these relationships longitudinally.

Who could benefit from this research

Good fit: Children born to mothers with HIV but uninfected (HEU) and children unexposed to HIV (HU) who are followed from birth into early adolescence, especially those in cohorts like Drakenstein in South Africa.

Not a fit: Adults, people without early-life medical records or biosamples, and individuals outside the cohort's geographic region are unlikely to directly benefit from this project.

Why it matters

Potential benefit: If successful, this work could identify early blood markers and infection-related pathways that help prevent or reduce cardiometabolic problems in children exposed to HIV.

How similar studies have performed: Previous cohort and metabolomics studies, including work by this team, have linked early infections and inflammation to pro-atherogenic metabolic patterns, but the full longitudinal link to adolescent cardiometabolic outcomes remains to be clarified.

Where this research is happening

Hartford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.